308 related articles for article (PubMed ID: 3083198)
1. The effect of high glucose and oxidative stress on lens metabolism, aldose reductase, and senile cataractogenesis.
Cheng HM; González RG
Metabolism; 1986 Apr; 35(4 Suppl 1):10-4. PubMed ID: 3083198
[TBL] [Abstract][Full Text] [Related]
2. Nonosmotic diabetic cataracts.
Malone JI; Lowitt S; Cook WR
Pediatr Res; 1990 Mar; 27(3):293-6. PubMed ID: 2138728
[TBL] [Abstract][Full Text] [Related]
3. The effect of an aldose reductase inhibitor (Sorbinil) on the level of metabolites in lenses of diabetic rats.
Gonzalez AM; Sochor M; McLean P
Diabetes; 1983 May; 32(5):482-5. PubMed ID: 6404681
[TBL] [Abstract][Full Text] [Related]
4. Lens metabolism and cellular effects of aldose reductase.
McLean P; Gonzalez AM; Sochor M; Hothersall JS
Diabet Med; 1985 May; 2(3):189-93. PubMed ID: 2952418
[No Abstract] [Full Text] [Related]
5. The effect of aldose reductase and its inhibition on sugar cataract formation.
Kador PF; Akagi Y; Kinoshita JH
Metabolism; 1986 Apr; 35(4 Suppl 1):15-9. PubMed ID: 3083204
[TBL] [Abstract][Full Text] [Related]
6. Effect of aldose reductase inhibitor (sorbinil) on integration of polyol pathway, pentose phosphate pathway, and glycolytic route in diabetic rat lens.
Gonzalez AM; Sochor M; Hothersall JS; McLean P
Diabetes; 1986 Nov; 35(11):1200-5. PubMed ID: 3093302
[TBL] [Abstract][Full Text] [Related]
7. The utilization of 13C and 31P nuclear magnetic resonance spectroscopy in the study of the sorbitol pathway and aldose reductase inhibition in intact rabbit lenses.
Williams WF; Odom JD
Exp Eye Res; 1987 Jun; 44(6):717-30. PubMed ID: 3115803
[TBL] [Abstract][Full Text] [Related]
8. Aldose reductase in diabetic cataracts.
Kinoshita JH; Kador P; Catiles M
JAMA; 1981 Jul; 246(3):257-61. PubMed ID: 6787220
[No Abstract] [Full Text] [Related]
9. Altered phosphate metabolism in the intact rabbit lens under high glucose conditions and its prevention by an aldose reductase inhibitor.
González RG; Barnett P; Cheng HM; Chylack LT
Exp Eye Res; 1984 Nov; 39(5):553-62. PubMed ID: 6440802
[TBL] [Abstract][Full Text] [Related]
10. Effects of the aldose reductase inhibitor sorbinil on the isolated cultured rat lens.
Yeh LA; Rafford CE; Beyer TA; Hutson NJ
Metabolism; 1986 Apr; 35(4 Suppl 1):4-9. PubMed ID: 3083208
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: an intervention study.
Obrosova IG; Fathallah L
Diabetologia; 2000 Aug; 43(8):1048-55. PubMed ID: 10990083
[TBL] [Abstract][Full Text] [Related]
12. Study of aldose reductase inhibition in intact lenses by 13C nuclear magnetic resonance spectroscopy.
Williams WF; Odom JD
Science; 1986 Jul; 233(4760):223-5. PubMed ID: 3088727
[TBL] [Abstract][Full Text] [Related]
13. Aldose reductase, NADPH and NADP+ in normal, galactose-fed and diabetic rat lens.
Lee SM; Schade SZ; Doughty CC
Biochim Biophys Acta; 1985 Sep; 841(3):247-53. PubMed ID: 3927985
[TBL] [Abstract][Full Text] [Related]
14. NIH conference. Aldose reductase and complications of diabetes.
Cogan DG; Kinoshita JH; Kador PF; Robison G; Datilis MB; Cobo LM; Kupfer C
Ann Intern Med; 1984 Jul; 101(1):82-91. PubMed ID: 6203454
[TBL] [Abstract][Full Text] [Related]
15. Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor.
Beyer-Mears A; Cruz E
Diabetes; 1985 Jan; 34(1):15-21. PubMed ID: 3917257
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of Zopolrestat and Sorbinil on lens myo-inositol influx.
Beyer-Mears A; Diecke FP; Mistry K; Cruz E
Pharmacology; 1997 Feb; 54(2):76-83. PubMed ID: 9088040
[TBL] [Abstract][Full Text] [Related]
17. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
Jacobson M; Sharma YR; Cotlier E; Hollander JD
Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448
[TBL] [Abstract][Full Text] [Related]
18. Raman spectroscopic study of the effect of aldose reductase inhibitor on experimental diabetic cataract.
Nozawa H; Yaginuma T; Mizuno A
Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):194-201. PubMed ID: 3133929
[No Abstract] [Full Text] [Related]
19. Efficacy of Alrestatin, an aldose reductase inhibitor, in human diabetic and nondiabetic lenses.
Chylack LT; Henriques HF; Cheng HM; Tung WH
Ophthalmology; 1979 Sep; 86(9):1579-85. PubMed ID: 121768
[TBL] [Abstract][Full Text] [Related]
20. Aldose reductase in diabetic complications of the eye.
Kinoshita JH; Fukushi S; Kador P; Merola LO
Metabolism; 1979 Apr; 28(4 Suppl 1):462-9. PubMed ID: 45423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
